Screening for Colon and Rectal Cancer

Wingo P.A. , Tong T. , Bolden S. Cancer statistics, 1995. CA Cancer J Clin. 1995; 45: 8–30.

Miller B.A. , Ries L.A.G. , Hankey B.F. Seer Cancer Statistics Review 1973–1990. National Cancer Institute, NIH Pub. No. 93–2789, 1993.

Potter J.D. , Slattery M.L. , Bostick R.M. Colon cancer: a review of the epidemiology. Epidemiol Rev. 1993; 15: 499–545.

Young G.P. , Rose I.S. , St John D.J.B. Haem in the gut. I. Fate of haemoproteins and the absorption of haem. J Gastroenterol Hepatol. 1989; 4: 537–545.

Young G.P. , St John D.J.B. Selecting an occult blood test for use as a screening tool for large bowel cancer. In: Rozen P. , Reich C.B. , Winawer S.J. , eds. Large Bowel Cancer: Policy, Prevention, Research and Treatment. Front Gastrointest Res. Vol 18. Basel: Karger; 1991: 135–156.

Young G.P. , St John D.J.B. , Rose I.S. Haem in the gut. Part II. Faecal excretion of haem and haem-derived porphyrins and their detection. J Gastroenterol Hepatol. 1990; 5: 194–203.

Rosenfield R.E. , Kochwa S. , Kaczera Z. Nonuniform distribution of occult blood in feces. Am J Clin Pathol. 1979; 71: 204–209.

Turunen M.J. , Liewendahl K. , Partanen P. Immunological detection of faecal occult blood in colorectal cancer. Br J Cancer. 1948; 49: 141–148.

Macrae F.A. , St John D.J.B. Relationship between patterns of bleeding and hemoccult sensitivity in patients with colorectal cancers or adenomas. Gastroenterology. 1982; 82: 891–898.

Greegor D.H. Diagnosis of large-bowel cancer in the asymptomatic patient. JAMA. 1967; 201: 943–945.

Knight K.K. , Fielding J.E. , Battista R.N. US Preventive Services Task Force: occult blood screening for colorectal cancer. JAMA. 1989; 261: 586–593.

Mandel J.S. , Bond J.H. , Church T.R. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med. 1993; 328: 1365–1371.

Winawer S.J. , Flehinger B.J. , Schottenfeld D. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst. 1993; 85: 1311–1318.

Selby J.V. , Friedman G.D. , Quesenberry C.P. Jr . Effects of fecal occult blood testing on mortality from colorectal cancer. a case-control study. Ann Intern Med. 1993; 118: 1–6.

Wahrendorf J. , Robra B.P. , Wiebelt H. Effectiveness of colorectal screening: results from a population-based case-control evaluation in Saarland, Germany. Eur J Cancer Prev. 1993; 2: 221–227.

Lazovich D. , Weiss N.S. , Stevens N.G. A case-control study to evaluate efficacy of screening for fecal occult blood. J Med Screen. 1995. In press.

St John D.J.B. Faecal occult blood tests: a critical review. In: Hardcastle J.D. , ed. Screening for Colorectal Cancer. Englewood, NJ: Normed Verlag; 1990: 55–68.

Allison J.E. , Tekawa I.S. , Ransom L.J. A comparison of fecal occult-blood tests for colorectal cancer screening. N Engl J Med. 1996; 334: 155–159.

Castiglione G. , Grazzini G. , Ciatto S. Guaiac and immunochemical tests for faecal occult blood in colorectal cancer screening. Br J Cancer. 1992; 65: 942–944.

Schwartz S. , Dahl J. , Ellefson M. The “HemoQuant” test: a specific and quantitative determination of heme (hemoglobin) in feces and other materials. Clin Chem. 1983; 29: 2061–2067.

Ahlquist D.A. , Wieand H.S. , Moertel C.G. Accuracy of fecal occult blood screening for colorectal neoplasia: a prospective study using Hemoccult and HemoQuant tests. JAMA. 1993; 269: 1262–1267.

Simon J.B. The pros and cons of fecal occult blood testing for colorectal neoplasms. Cancer Metastasis Rev. 1987; 6: 397–411.

Mandel J.S. , Bond J.H. , Bradley M. Sensitivity, specificity and positive predictivity of the Hemoccult test in screening for colorectal cancers. Gastroenterology. 1989; 97: 597–600.

St John D.J. , Young G.P. , Alexeyeff M.A. Evaluation of new occult blood tests for detection of colorectal neoplasia. Gastroenterology. 1993; 104: 1661–1668.

Simon J.B. Occult blood screening for colorectal carcinoma: a critical review. Gastroenterology. 1985; 88: 820–837.

Macrae F.A. , St John D.J.B. , Caligiore P. Optimal dietary conditions for Hemoccult testing. Gastroenterology. 1982; 82: 899–903.

Gilbertson V.A. , Church T.R. , Greive F.J. The design of a study to assess occult blood screening for colon cancer. J Chron Dis. 1980; 33: 107–114.

Kewenter J. , Brevinge H. , Engaras B. Follow-up after screening for colorectal neoplasms with fecal occult blood testing in a controlled trial. Dis Colon Rectum. 1994; 37: 115–119.

Thomas W.M. , Hardcastle J.D. An update on the Nottingham trial of fecal occult blood screening for colorectal cancer. In: Miller A.B. , Chamberlain J. , Day N.E. , eds. Cancer Screening. Cambridge University Press, 106–115, 1991.

Hardcastle J.D. Randomized control trial of faecal occult blood screening for colorectal cancer: results for the first 144,103 patients. Eur J Cancer Prev. 1991; 1: 21.

Thomas W.M. , Pye G. , Hardcastle J.D. Screening for colorectal carcinoma: an analysis of the sensitivity of haemoccult. Br J Surg. 1992; 79: 833–835.

Krönborg O. , Fenger C. , Worm J. Causes of death during the first 5 years of a randomized trial of mass screening for colorectal cancer with fecal occult blood test. Scand J Gastroenterol. 1992; 27: 47–52.

Bedenne L. , Faivre J. , Boutron M.C. Adenoma-carcinoma sequence or “de novo” carcinogenesis? A study of adenomatous remnants in a population-based series of large bowel cancers. Cancer. 1992; 69: 883–888.

Faivre J. , Arveux P. , Milan C. Participation in mass screening for colorectal cancer: results of screening and rescreening from the Burgundy study. Eur J Cancer Prev. 1991; 1: 49–55.

Winawer S.J. , Schottenfeld D. , Flehinger B.J. Colorectal cancer screening. J Natl Cancer Inst. 1991; 83: 243–253.

Arveux P. , Durand G. , Milan C. Views of a general population on mass screening of colorectal cancer: the Burgundy Study. Prev Med. 1992; 21: 574–581.

Moss S.M. Case-control studies of screening. Int J Cancer. 1991; 20: 1–6.

Newcomb P.A. , Norfleet R.G. , Storer B.E. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst. 1992; 84: 1572–1575.

Lieberman D. Screening/early detection model for colorectal cancer: why screen? Cancer. 1994; 74: 2023–2027.

Dukes C.E. Simple tumors of the large intestine and their relationship to cancer. Br J Surg. 1925; 13: 720.

Bronner M.P. , Haggitt R.C. The Polyp-cancer sequence: do all cancers arise from benign adenomas? In: Sivak M.V. , ed. Gastrointestinal Endoscopy. Clinics of North America. Vol 3. Philadelphia, Pa: WB Saunders Co; 1993: 611–622.

Kuramoto S. , Oohara T. How do colorectal cancers develop? Cancer. 1995; 75(Suppl 6): 1534–1538.

Winawer S.J. , Zauber A.G. , Ho M.N. Prevention of colorectal cancer by colonoscopic polypectomy: the National Polyp Study Workgroup. N Engl J Med. 1993; 329: 1977–1981.

Winawer S.J. , O'Brien M.J. , Waye J.D. Risk and surveillance of individuals with colorectal polyps: The WHO Collaborating Centre for the Prevention of Colorectal Cancer. Bull World Health Organ. 1990; 68: 789–795.

Winawer S.J. , Zauber A.G. , O'Brien M.J. Design, methods, and characteristics of patients with newly diagnosed polyps: the National Polyp Study Workgroup. Cancer. 1992; 70: 1236–1245.

Winawer S.J. , Zauber A. , Diaz B. The National Polyp Study: temporal sequence of evolving colorectal cancer from the normal colon. Gastrointest Endos. 1987; 33: 167.

Jrgensen O.D. , Krönborg O. , Fenger C. The Funen Adenoma Follow-up Study: characteristics of patients and initial adenomas in relation to severe dysplasia. Scand J Gastroenterol. 1993; 28: 239–243.

Atkin W.S. , Morson B.C. , Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med. 1992; 326: 658–662.

Ransohoff D.F. , Lang C.A. Sigmoidoscopy screening in the 1990s. JAMA. 1993; 269: 1278–1281.

Atkin W.S. , Cuzick J. , Northover J.M.A. Prevention of cancer by once-only sigmoidoscopy. Lancet. 1993; 341: 736–740.

Gilbertsen V.A. , Nelms J.M. The prevention of invasive cancer of the rectum. Cancer. 1978; 41: 1137–1139.

Miller A.B. Review of sigmoidoscopy screening for colorectal cancer. In: Chamberlain J. , Miller A.B. , eds. Screening for Gastrointestinal Cancer. Toronto, Canada: Hans Huber; 1988: 307.

Cutler J.L. , Ramcharon S. , Feldman R. Multiphasic checkup evaluation study I. Methods. Prev Med. 1973; 2: 197–206.

Dales L.G. , Friedman G.D. , Ramcharon S. Multiphasic checkup evaluation study: outpatient clinic utilization, hospitalization and mortality experience after seven years. Prev Med. 1973; 2: 221–235.

Friedman G.D. , Collen M.F. , Fireman B.H. Multiphasic health checkup evaluation: a 16-year follow-up. J Chron Dis. 1986; 39: 453–463.

Selby J.V. , Friedman G.D. , Quesenberry C.P. Jr . A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992; 326: 653–657.

Lieberman D. Screening colonoscopy. Has the time come? In: Swak M.V. , ed. Gastrointestinal Endoscopy Clinics of America. Vol 3. Philadelphia, Pa: WB Saunders Co; 1993: 673–682.